Abstract:Most clinical MRSA (methicillin-resistant S. aureus) isolates exhibit low-level β-lactam resistance (oxacillin MIC 2–4 μg/ml) due to the acquisition of a novel penicillin binding protein (PBP2A), encoded by mecA. However, strains can evolve high-level resistance (oxacillin MIC ≥256 μg/ml) by an unknown mechanism. Here we have developed a robust system to explore the basis of the evolution of high-level resistance by inserting mecA into the chromosome of the methicillin-sensitive S. aureus SH1000. Low-level mecA-dependent oxacillin resistance was associated with increased expression of anaerobic respiratory and fermentative genes. High-level resistant derivatives had acquired mutations in either rpoB (RNA polymerase subunit β) or rpoC (RNA polymerase subunit β') and these mutations were shown to be responsible for the observed resistance phenotype. Analysis of rpoB and rpoC mutants revealed decreased growth rates in the absence of antibiotic, and alterations to, transcription elongation. The rpoB and rpoC mutations resulted in decreased expression to parental levels, of anaerobic respiratory and fermentative genes and specific upregulation of 11 genes including mecA. There was however no direct correlation between resistance and the amount of PBP2A. A mutational analysis of the differentially expressed genes revealed that a member of the S. aureus Type VII secretion system is required for high level resistance. Interestingly, the genomes of two of the high level resistant evolved strains also contained missense mutations in this same locus. Finally, the set of genetically matched strains revealed that high level antibiotic resistance does not incur a significant fitness cost during pathogenesis. Our analysis demonstrates the complex interplay between antibiotic resistance mechanisms and core cell physiology, providing new insight into how such important resistance properties evolve.Methicillin resistant Staphylococcus aureus (MRSA) places a great burden on human healthcare systems. Resistance is mediated by the acquisition of a non-native penicillin-binding protein 2A (PBP2A), encoded by mecA. MRSA strains are resistant to virtually all β-lactam antibiotics, and can shift from being low- to high-level resistant. Prior studies have revealed the involvement of components of the core genome in increased resistance, but the underlying mechanism is still unknown. In this study, we have found that increased resistance is associated with mutations in either rpoB (RNA polymerase subunit β) or rpoC (RNA polymerase subunit β') resulting in slower growth and elevated levels of PBP2A. Furthermore, transcript profiling revealed that insertion of mecA triggered metabolic imbalance by altering anaerobic and fermentative gene expression, accompanied by low-level resistance whereas, acquisition of rpoB and rpoC mutations reversed gene expression to wild-type level and enabled cells to become highly-resistant. The mutations also affected RNA polymerase activity. A set of matched strains revealed that changes in antibiotic resistance levels do not have a significant cost in terms of pathogenic potential. Our study reveals a novel effect of mecA acquisition on central metabolism and sheds light on potential pathways essential for high-level resistance.

RNA-seq-based transcriptome analysis of a cefquinome-treated, highly resistant, and virulent MRSA strain

Two novel plasmids harbouring the multiresistance gene cfr in porcine Staphylococcus equorum

Staphylococcal Cassette Chromosome Mec Amplification As a Mechanism for Ceftobiprole Resistance in Clinical Methicillin-Resistant Staphylococcus Aureus Isolates.

Comparative virulence studies and transcriptome analysis of Staphylococcus aureus strains isolated from animals

Probiotic disruption of quorum sensing reduces virulence and increases cefoxitin sensitivity in methicillin-resistant Staphylococcus aureus

Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin

Genomic Insights of a Methicillin-Resistant Biofilm-Producing Staphylococcus aureus Strain Isolated From Food Handlers

Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression

Antibacterial Pathway of Cefquinome Against Staphylococcus Aureus Based on Label-Free Quantitative Proteomics Analysis.

Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in Acinetobacter baumannii

Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates

Beyond the Wild MRSA: Genetic Features and Phylogenomic Review of mecC-Mediated Methicillin Resistance in Non-aureus Staphylococci and Mammaliicocci

SCCmec amplification as a mechanism for ceftobiprole resistance in clinical MRSA isolates

Phenotypic and molecular characterization of clinically isolated antibiotics-resistant S. aureus (MRSA), E. coli (ESBL) and Acinetobacter 1379 bacterial strains

Tracking Cefoperazone/Sulbactam Resistance Development in Vivo in A. Baumannii Isolated from a Patient with Hospital-Acquired Pneumonia by Whole-Genome Sequencing

Exploiting the synergistic antibacterial activity of shikimic acid and ceftiofur against methicillin-resistant Staphylococcus aureus

RNA-Seq-based transcriptome analysis of methicillin-resistant Staphylococcus aureus biofilm inhibition by ursolic acid and resveratrol

Linezolid and Rifampicin Combination to Combat Cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection

Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance

Modulation Of Ccrab Expression And Sccmec Excision By An Inverted Repeat Element And Sars In Methicillin-Resistant Staphylococcus Aureus

Transcriptome analysis of the biofilm formed by methicillin-susceptible Staphylococcus aureus